These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 5458259)

  • 1. Pelvic exenteration for carcinoma of the uterine cervix. A 15-year experience.
    Ketcham AS; Deckers PJ; Sugarbaker EV; Hoye RC; Thomas LB; Smith RR
    Cancer; 1970 Sep; 26(3):513-21. PubMed ID: 5458259
    [No Abstract]   [Full Text] [Related]  

  • 2. Pelvic exenteration for carcinoma of the cervix: analysis of 252 cases.
    Rodriguez Cuevas H; Torres A; de la Garza M; Hernandez D; Herrera L
    J Surg Oncol; 1988 Jun; 38(2):121-5. PubMed ID: 3288809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pelvic exenteration: a morbidity and mortality analysis of a seven-year experience.
    Anthopoulos AP; Manetta A; Larson JE; Podczaski ES; Bartholomew MJ; Mortel R
    Gynecol Oncol; 1989 Nov; 35(2):219-23. PubMed ID: 2807013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pelvic exenteration: a critical analysis of a ten-year experience with the use of the team approach.
    Galante M; Hill EC
    Trans Pac Coast Obstet Gynecol Soc; 1970; 38():59-68. PubMed ID: 5001569
    [No Abstract]   [Full Text] [Related]  

  • 5. Pelvic exenteration for primary carcinoma of the uterine cervix.
    Deckers PJ; Ketcham AS; Sugerbaker EV; Hoye RC; Thomas LB
    Obstet Gynecol; 1971 May; 37(5):647-59. PubMed ID: 5091743
    [No Abstract]   [Full Text] [Related]  

  • 6. Radical hysterectomy and pelvic lymphadenectomy for carcinoma of the uterine cervix.
    Ketcham AS; Hoye RC; Taylor PT; Deckers PJ; Thomas LB; Chretien PB
    Cancer; 1971 Nov; 28(5):1272-7. PubMed ID: 5125675
    [No Abstract]   [Full Text] [Related]  

  • 7. Major morbidity after pelvic exenteration: a seven-year experience.
    Roberts WS; Cavanagh D; Bryson SC; Lyman GH; Hewitt S
    Obstet Gynecol; 1987 Apr; 69(4):617-21. PubMed ID: 3822305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical management of advanced and recurrent cervical carcinoma: the place of pelvic exenteration.
    Monaghan JM
    Clin Obstet Gynaecol; 1985 Mar; 12(1):169-82. PubMed ID: 3888482
    [No Abstract]   [Full Text] [Related]  

  • 9. Pelvic exenteration for recurrent or persistent cervical cancer: experience of five years at the National Cancer Institute in Mexico.
    Terán-Porcayo MA; Zeichner-Gancz I; del-Castillo RA; Beltrán-Ortega A; Solorza-Luna G
    Med Oncol; 2006; 23(2):219-23. PubMed ID: 16720922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelvic exenteration for adenocarcinoma of the uterine cervix.
    Crozier M; Morris M; Levenback C; Lucas KR; Atkinson EN; Wharton JT
    Gynecol Oncol; 1995 Jul; 58(1):74-8. PubMed ID: 7789894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anterior pelvic exenteration.
    Hatch KD; Shingleton HM; Soong SJ; Baker VV; Gelder MS
    Gynecol Oncol; 1988 Sep; 31(1):205-16. PubMed ID: 3410348
    [No Abstract]   [Full Text] [Related]  

  • 12. Pelvic exenteration: analysis of 296 patients.
    Rutledge FN; Smith JP; Wharton JT; O'Quinn AG
    Am J Obstet Gynecol; 1977 Dec; 129(8):881-92. PubMed ID: 930972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic exenteration for carcinoma of the cervix.
    Ingersoll FM; Ulfelder H
    N Engl J Med; 1966 Mar; 274(12):648-51. PubMed ID: 17926376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical aspects of cervical carcinoma.
    DiSaia PJ
    Cancer; 1981 Jul; 48(2 Suppl):548-59. PubMed ID: 7023664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic exenteration for late second cancers of the uterne cervic after earlier irradiation.
    Deckers PJ; Sugarbaker EV; Pilch YH; Ketcham AS
    Ann Surg; 1972 Jan; 175(1):48-54. PubMed ID: 5060856
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pelvic exenteration for carcinoma of the uterine cervix (author's transl)].
    Mayer M; Bobin JY; Colon J; Borg G
    Bull Cancer; 1980; 67(1):70-7. PubMed ID: 7362891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for curative pelvic exenterations in patients with recurrent uterine cervical or vaginal cancer.
    Sardain H; Lavoué V; Laviolle B; Henno S; Foucher F; Levêque J
    Int J Gynecol Cancer; 2014 Nov; 24(9):1679-85. PubMed ID: 25254565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Curative pelvic exenteration for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy. A systematic review].
    Sardain H; Lavoué V; Foucher F; Levêque J
    J Gynecol Obstet Biol Reprod (Paris); 2016 Apr; 45(4):315-29. PubMed ID: 26874666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphadenectomy in pelvic exenteration for recurrent cervix cancer.
    Barber HR; Jones W
    JAMA; 1971 Mar; 215(12):1945-9. PubMed ID: 5107835
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pelvic exenteration in cancer of the cervix uteri. Analysis of 252 cases].
    Torres Lobatón A; Rodríguez Cuevas H; Velázquez Venegas GJ; Díaz Rodríguez LR
    Ginecol Obstet Mex; 1985 Nov; 53():297-302. PubMed ID: 3836153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.